Posted by Equitymaster India reported its first COVID-19 case on January 30, 2020, in Kerala. Infections thereafter rose in many other states, and... ...http://feeds.equitymaster.com/~r/TheOutsideView/~3/FIc-vMeeSwA/detail.asp
Avenue Supermarts, Dr Reddy#39;s Labs, IndusInd Bank, Cadila Healthcare, Prestige Estates Projects, Sadbhav Infrastructure Project, Likhitha... ...https://www.moneycontrol.com/news/stocksnews/stocksthe-news-|-hdfc-bank-iifl-securities-route-mobile-hsil-ril-shoppers-stop-srf_14378621.html
New Delhi: Drug firm Zydus Cadila on Friday said it has received final approval from the US health regulator to market Fingolimod capsules and... ...https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/zydus-cadila-gets-usfda-nod-to-market-fingolimod-capsules-verapamil-hydrochloride-injection/articleshow/78716968.cms
Industries (down 0.58 per cent) and Alkem Laboratories (down 0.35 per cent) were the top losers in the index. The Nifty Pharma index was trading... ...https://economictimes.indiatimes.com/markets/stocks/news/stock-market-update-nifty-pharma-index-up-over-1-cadila-healthcarenbsprises-3/articleshow/78697549.cms
Posted by Equitymaster NARAYANA HRUDAYALAYA share price has zoomed 5% and is presently trading at Rs 368. Meanwhile, the BSE HEALTHCARE Index is at... ...http://feeds.equitymaster.com/~r/TodaysMarket/~3/f0MP3oWIhhE/indian-share-markets-updates.asp
The company was formed way back in...